Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 18, 2008Journal of Medicinal ChemistryOpen Access

Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States

View Full Paper
Ask AI
Bookmark
Share

Authors

IKIrina KufarevaUniversity of California, San DiegoRARuben AbagyanEngelhardt Institute of Molecular Biology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kufareva et al. (2008) studied this question.

synapsesocial.com/papers/69ffd8572ff633f36577b678https://doi.org/10.1021/jm8010299
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Design and Discovery of Small Molecules Targeting Raf-1 Kinase2002 · 148 citations
  2. 2Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors2007 · 220 citations
  3. 3Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors2008 · 5 citations
  4. 4The Protein Data Bank2000 · 40,662 citations
  5. 5The RET Kinase Inhibitor NVP-AST487 Blocks Growth and Calcitonin Gene Expression through Distinct Mechanisms in Medullary Thyroid Cancer Cells2007 · 117 citations